Laminin and fibronectin promote the chemotaxis of human malignant plasma cell lines

Blood. 1995 Jul 15;86(2):719-25.

Abstract

We examined chemotaxis of human plasma cells (PCs) in response to extracellular matrix proteins (ECMs) in the human PC cell lines FR4ds and OPM-1ds. The FR4ds cells expressed beta 1+, beta 3-, alpha 2-, alpha 3-, alpha 4+, alpha 5+, alpha 6+, and alpha v+ integrins, whereas the OPM-1ds cells expressed beta 1+, beta 3-, alpha 2-, alpha 3+, alpha 4+, alpha 5-, alpha 6+, and alpha v+. Fibronectin (FN) and laminin (LN) promoted the chemotaxis of the PCs. An inhibitory assay with anti-integrin monoclonal antibodies (MoAbs) showed that anti-alpha 4 MoAb partially inhibited the chemotaxis of FR4ds and completely inhibited the chemotaxis of OPM-1ds. Anti-alpha 5 MoAb alone had no effect on either of these two lines. Nevertheless, anti-alpha 5 MoAb completely inhibited chemotaxis when it was added with anti-alpha 4 in FR4ds, demonstrating a novel complementary role of VLA-5 toward VLA-4 in the chemotaxis induced by FN. LN facilitated chemotaxis both in OPM-1ds expressing alpha 3 and alpha 6 integrins and in FR4ds expressing alpha 6 integrin alone. Anti-alpha 6 MoAb completely inhibited FR4ds chemotaxis, whereas anti-alpha 3 and -alpha 6 MoAb had synergistic inhibitory effects on the chemotaxis of OPM-1ds. These results indicated that the distribution of PCs in human tissue are determined by at least two factors: the concentration of the ECM proteins FN and LN and the expression of integrins.

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Cell Adhesion / drug effects
  • Cell Size / drug effects
  • Chemotaxis / drug effects*
  • Fibronectins / pharmacology*
  • Humans
  • Laminin / pharmacology*
  • Neoplasm Proteins / metabolism
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / physiology
  • Oligopeptides / pharmacology
  • Plasma Cells / drug effects*
  • Plasma Cells / physiology
  • Plasmacytoma / pathology*
  • Receptors, Fibronectin / antagonists & inhibitors
  • Receptors, Fibronectin / immunology
  • Receptors, Fibronectin / metabolism
  • Receptors, Laminin / antagonists & inhibitors
  • Receptors, Laminin / immunology
  • Receptors, Very Late Antigen / metabolism
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Fibronectins
  • Laminin
  • Neoplasm Proteins
  • Oligopeptides
  • Receptors, Fibronectin
  • Receptors, Laminin
  • Receptors, Very Late Antigen
  • arginyl-glycyl-aspartic acid
  • glycyl-arginyl-glycyl-aspartyl-seryl-proline